(Q53588433)

15 May 2018

title

Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. (English)

1 reference

15 May 2018

1 reference

1 reference

1 reference

5

1 reference

15 May 2018

author name string

Danny Soon

1

1 reference

15 May 2018

Prajakti A Kothare

2

1 reference

15 May 2018

Helle Linnebjerg

3

1 reference

15 May 2018

Soomin Park

4

1 reference

15 May 2018

Kenneth F Mace

6

1 reference

15 May 2018

Stephen D Wise

7

1 reference

15 May 2018

publication date

1 October 2006

1 reference

15 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

15 May 2018

volume

46

1 reference

15 May 2018

issue

10

1 reference

15 May 2018

page(s)

1179-1187

1 reference

15 May 2018

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effect of exenatide on the steady-state pharmacokinetics of digoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270006291622

21 January 2018

Identifiers

DOI

10.1177/0091270006291622

1 reference

15 May 2018

1 reference

15 May 2018